Annals of Nuclear Medicine

, Volume 14, Issue 4, pp 311–313 | Cite as

FDG PET in the clinical evaluation of sarcoidosis with bone lesions

  • Atsushi Kobayashi
  • Tetsuya Shinozaki
  • Yasuaki Shinjyo
  • Katsuya Kato
  • Noboru Oriuchi
  • Hideomi Watanabe
  • Kenji Takagishi
Case Reports

Abstract

We report a case of sarcoidosis with osseous involvement. Whole-body fluorine-18-fluorodeoxy-glucose (FDG) PET scanning demonstrated multiple sites of FDG uptake in the hilar lymph nodes, right ulna, bilateral feet, and subcutaneous tissue of the extremities. FDG PET scanning provides useful information for the detection of sarcoidosis with systemic distribution, even when osseous lesions are included.

Key words

fluorine-18-fluorodeoxyglucose PET sarcoidosis bone lesions 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients.Q J Med 52 (208): 525–533, 1983.PubMedGoogle Scholar
  2. 2.
    Pietinalho A, Hiraga Y, Hosoda Y, Löfroos A-B, Yamaguchi M, Selroos O. The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study.Sarcoidosis 12: 61–67, 1995.PubMedGoogle Scholar
  3. 3.
    Gunter B. Sarcoidosis.Orthopedics 18: 214–218, 1995.Google Scholar
  4. 4.
    Alavi A, Buchpiguel CA, Loessner A. Is there a role for FDG PET imaging in the management of patients with sarcoidosis?J Nucl Med 35: 1650–1652, 1994.PubMedGoogle Scholar
  5. 5.
    Pino JGD, Ulloa AD, Lovic A, Relea MF. Sarcoidosis of the hand and wrist: a report of two cases.J Hand Surg 22A: 942–945, 1997.Google Scholar
  6. 6.
    Aoki J, Watanabe H, Shinozaki T, Tokunaga M, Inoue T, Endo K. FDG-PET in differential diagnosis and grading of chondrosarcomas.J Comput Assist Tomogr 23: 603–608, 1999.CrossRefPubMedGoogle Scholar
  7. 7.
    Watanabe H, Shinozaki T, Yanagawa T, Aoki J, Tokunaga M, Inoue T, et al. Glucose metabolic analysis of musculoskeletal tumors using fluorine-18-FDG PET as an aid to preoperative planning.J Bone Joint Surg 82-B: 760–767, 2000.CrossRefGoogle Scholar
  8. 8.
    Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxy-glucose in sarcoidosis.J Nucl Med 35: 1647–1649, 1994.PubMedGoogle Scholar
  9. 9.
    Edeiken J.Roentgen Diagnosis of Disease of Bone. 3rd ed., Baltimore, Williams & Wilkins, pp. 808–816, 1891.Google Scholar
  10. 10.
    Landi A, Brooks D, Santis GD. Sarcoidosis of the hand-report of two cases.J Hand Surg 8: 197–200, 1983.Google Scholar
  11. 11.
    Bushara KO, Petermann G, Waclawik AJ, Brown WD, Schutta HS. Sarcoidosis of the spinal cord with extensive vertebral involvement: a case report.Comput Med Imaging Graph 19: 443–446, 1995.CrossRefPubMedGoogle Scholar
  12. 12.
    Shinozaki T, Watanabe H, Aoki J, Fukuda T, Shirakura K, Takagishi K. Imaging features of subcutaneous sarcoidosis.Skeletal Radiol 27: 359–364, 1998.CrossRefPubMedGoogle Scholar
  13. 13.
    Hoefnagel CA, Bruning PF, Cohen P, Marcuse HR, van-der-Schoot JB. Detection of lung metastases from osteosarcoma by scintigraphy using99mTc-methylene diphosphonate.Diagn Imaging 50: 277–284, 1981.PubMedGoogle Scholar
  14. 14.
    Lin WY, Kao CH, Hsu CY, Liao SQ, Wang SJ, Yeh SH. The role of Tc-99m MDP and Ga-67 imaging in the clinical evaluation of malignant fibrous histiocytoma.Clin Nucl Med 19: 996–1000, 1994.CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2000

Authors and Affiliations

  • Atsushi Kobayashi
    • 2
  • Tetsuya Shinozaki
    • 2
  • Yasuaki Shinjyo
    • 2
  • Katsuya Kato
    • 1
  • Noboru Oriuchi
    • 1
  • Hideomi Watanabe
    • 2
  • Kenji Takagishi
    • 2
  1. 1.Department of Nuclear MedicineGunma University Faculty of MedicineGunmaJapan
  2. 2.Department of Orthopedic SurgeryGunma University Faculty of MedicineGunmaJapan

Personalised recommendations